AstraZeneca ties up with Emergent BioSolutions to make COVID-19 vaccine in U.S.

The deal comes weeks after the United States pledged up to $1.2 billion to secure 300 million doses of AstraZeneca’s vaccine, which is among the first to move into mid-stage trials. AstraZeneca has said that the first indication of the effectiveness of its vaccine would likely be available in June or July.

from Yahoo Finance https://ift.tt/2UA8QaT